Oversold Signals Illuminate CONMED’s Future Potential (CNMD) Oversold Signals Illuminate CONMED’s Future Potential (CNMD)

Avatar photo

As renowned investor Warren Buffett advises, time to pounce on a stock is when fear is pervasive and steer clear when it’s exuberance. This is precisely where the Relative Strength Index (RSI) comes into play – a technical indicator gauging a stock’s momentum on a scale of zero to 100. When the RSI reading dips below 30, it signals an oversold condition.

On the recent Friday trading, CONMED Corp (Symbol: CNMD) nosedived into the oversold territory, chalking up an RSI reading of 29.97, with share prices plummeting to $80.93. To put things in perspective, the S&P 500 ETF (SPY) currently touts an RSI reading of 63.7. For bullish investors, CNMD’s RSI at 29.97 could serve as a cue that the recent sell-off is tapering and potentially cue entry points on the buying side. The chart below encapsulates CNMD’s one-year performance:

CONMED Corp 1 Year Performance Chart


Per the chart, CNMD’s 52-week range oscillates between a low of $80.01 per share to a high of $138.47. This compares to the last trade at $81.11.

Discover the 9 other oversold stocks you need to know about!

Also see:

• Chase Coleman Stock Picks
• Funds Holding ATVI
• CCG Historical Stock Prices

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.

The free Daily Market Overview 250k traders and investors are reading

Read Now